Trial intelligence / Profile preview

NUEVA: BCG Vaccine for COVID-19 in Healthcare Workers

NCT04632537Phase 3Withdrawn

Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Start
Dec 2020
Primary completion
Mar 2021
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 3 trial of bcg vaccine in coronavirus disease 2019 (COVID-19), sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine. Planned start Dec 2020; status: withdrawn.

02

Drugs

bcg vaccine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04632537.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04632537.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call